MHC class II expression influences the composition and distribution of immune cells in the metastatic colorectal cancer microenvironment Journal Article


Authors: Griffith, B. D.; Turcotte, S.; Lazarus, J.; Lima, F.; Bell, S.; Delrosario, L.; McGue, J.; Krishnan, S.; Oneka, M. D.; Nathan, H.; Smith, J. J.; D’Angelica, M. I.; Shia, J.; Di Magliano, M. P.; Rao, A.; Frankel, T. L.
Article Title: MHC class II expression influences the composition and distribution of immune cells in the metastatic colorectal cancer microenvironment
Abstract: Despite advances in therapy over the past decades, metastatic colorectal cancer (mCRC) remains a highly morbid disease. While the impact of MHC-I on immune infiltration in mCRC has been well studied, data on the consequences of MHC-II loss are lacking. Multiplex fluorescent immunohistochemistry (mfIHC) was performed on 149 patients undergoing curative intent resection for mCRC and stratified into high and low human leukocyte antigen isotype DR (HLA-DR) expressing tumors. Intratumoral HLA-DR expression was found in stromal bands, and its expression level was associated with different infiltrating immune cell makeup and distribution. Low HLA-DR expression was associated with increased intercellular distances and decreased population mixing of T helper cells and antigen-presenting cells (APC), suggestive of decreased interactions. This was associated with less co-localization of tumor cells and cytotoxic T lymphocytes (CTLs), which tended to be in a less activated state as determined by Ki67 and granzyme B expression. These findings suggest that low HLA-DR in the tumor microenvironment of mCRC may reflect a state of poor helper T-cell interactions with APCs and CTL-mediated anti-tumor activity. Efforts to restore/enhance MHC-II presentation may be a useful strategy to enhance checkpoint inhibition therapy in the future. © 2022 by the authors.
Keywords: colon cancer; immuno-oncology; multiplex immunohistochemistry
Journal Title: Cancers
Volume: 14
Issue: 17
ISSN: 2072-6694
Publisher: MDPI  
Date Published: 2022-09-01
Start Page: 4092
Language: English
DOI: 10.3390/cancers14174092
PROVIDER: scopus
PMCID: PMC9454847
PUBMED: 36077630
DOI/URL:
Notes: Article -- Export Date: 3 October 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jinru Shia
    720 Shia
  2. Jesse Joshua Smith
    227 Smith